Negative Pressure Wound Therapy (NPWT) is an advance wound care therapy that applies sub-atmospheric or negative pressure to a wound in a closed drainage system. NPWT devices uses an electrical as well as a mechanical suction pump to continuously or intermittently convey negative pressure through connecting tubes to specially designed wound dressings kits that include resilient foam and gauze dressings and thereby promote faster wound healing. NPWT promotes wound healing by reducing edema, by stimulating granulation tissue and cell proliferation as well as by increasing blood circulation. NPWT systems can be used for the treatment of surgical wounds, traumatic wounds, chronic wounds such as diabetic foot ulcers and venous stasis ulcers as well as pressure sores. NPWT systems are segmented on the basis of type of devices into conventional NPWT systems and single use NPWT systems. Further, conventional NPWT systems are bifurcated on the basis of disposables into canisters, pumps and dressing kits. In addition, NPWT systems can also be used for the treatment of injuries associated with burns and meshed skin grafts.
The primary factors contributing to the growth of this market are globally increasing geriatric population; as well as increasing incidence and prevalence rate of chronic diseases such as cancer and diabetes leading to rise in chronic wounds. Moreover, high awareness about advance wound care devices and patient preference for the treatment with minimum side-effects are also driving the growth of this market.
In products segment, conventional NPWT systems account for the largest market segment while, single use NPWT systems market segment is growing with highest CAGR of approximately17 % during forecast period from 2014 to 2020. NPWT market is witnessing a paradigm shift from usage of conventional NPWT systems towards single use NPWT systems owing to preference of patients towards portable and cost effective wound care devices. This shift in preference is mainly related to convenience of patients since they try to avoid bulky and expensive conventional NPWT systems compared to portable single use NPWT systems.
Rising Investments in Emerging Markets Fueling Growth
North America is the most prominent market for negative pressure wound therapy at the moment, driven by increasing levels of patient awareness, rapidly aging population, growing prevalence of chronic diseases, high percentage of diabetic population, and favorable and supportive reimbursement policies. Europe is also a key market for negative pressure wound therapy, propelled by increased prevalence of chronic wounds and high incidence of transit accidents.
However, emerging economies have been identified as the most lucrative market for negative pressure wound therapy, thanks to rising investments in healthcare and development of novel technologies. Asia Pacific is anticipated to witness the highest growth among other regional markets and this development can be attributed to supportive government policies, strong economic development, increased demand for advanced wound care products, and rise in healthcare expenditure.
On the down side, high cost of advanced wound care devices, unfavorable reimbursement policies in certain countries, and reluctance in adopting technologically advanced devices in some regions are anticipated to restrict the growth of the market.
Realizing the potential of negative pressure wound therapy, the competition within the global market has increased, making room for advanced and more convenient solutions. Some of the leading vendors engaged in the global negative pressure wound therapy market are Devon Medical, Inc., Medela AG, Genadyne Biotechnologies, Inc., ConvaTec, Inc., Kinetic Concepts, Inc., ArjoHuntleigh International AB, Prospera Technologies LLC, Talley Group Limited, Smith & Nephew PLC, and Mölnlycke Health Care AB.
Gynecological devices comprise medical equipment required for examination, diagnosis, and treatment of conditions associated with the female reproductive system. Introduction of advanced techniques and devices such as magnetic resonance imaging, computed tomography, and ultrasound has resulted in tremendous growth of the global gynecological devices market across the globe.
In 2014, the global market for gynecological devices was worth US$14.9 bn and is estimated to reach a value of US$22.6 bn by the end of 2023. The market is expected to exhibit a healthy 4.80% CAGR between 2015 and 2023.
Rising Prevalence of Gynecological Diseases to Drive Global Gynecological Devices Market
The changing lifestyle of the female population in the modern world has abruptly augmented its healthcare requirements. These healthcare requirements are majorly due to delayed marriages, delayed childbirth, and lower fertility rates. In addition, the growing awareness regarding healthy lifestyles has resulted in increased demand for advanced gynecological treatments around the world. Moreover, the prevalence of gynecological diseases such as uterine fibroids, menorrhagia, and cervical cancer has been increasing tremendously, resulting in high demand for gynecological procedures and devices. These factors have offered opportunities to medical device manufacturers to introduce devices providing quick recovery, minimal discomfort, and better efficiency for patients. However, delay in the approvals from regulatory authorities is the major restraining factor for the growth of the global gynecological devices market.
Based on product type, the global market for gynecological devices can be broadly classified into surgical devices, diagnostic imaging systems, hand instruments, and gynecological chairs. Presently, the surgical devices segment holds the largest share in the global gynecological devices market. Technological advancements in the medical devices industry have offered several devices such as fluid management systems, endometrial ablation devices, contraceptive devices, endoscopy devices, and female sterilization devices. These devices have helped in providing minimally invasive surgical procedures resulting in a reduced risk of infection and minimal bleeding. On the flip side, the diagnostic imaging systems segment is anticipated to exhibit a progressive 5.80% CAGR between 2015 and 2023. Technological developments in ultrasound systems such as color imaging, spectral Doppler, and 3D imaging are some of the major factors that are driving the diagnostic imaging systems segment.
Presence of Large Patient Pool to Drive Asia Pacific Market for Gynecological Devices
Based on geography, the global market for gynecological devices can be divided into Latin America, North America, Europe, Asia Pacific, and Rest of the World. In 2014, the North America gynecological devices market accounted for the largest market share and is estimated to remain in the leading position in the next few years. On the other hand, the Asia Pacific gynecological devices market is expected to grow substantially in the next few years owing to several factors such as the developing macroeconomic environment, growing preference for minimally invasive procedures, and the presence of a large patient pool. The Asia Pacific gynecological devices market is anticipated to reach a value of US$6.2 bn by the end of 2023.
The prominent players operating in the global gynecological devices market are Hologic, Inc., Medtronic, Inc., Boston Scientific Corporation, Richard Wolf GmbH, CooperSurgical, Inc., Ethicon, Inc., Karl Storz GmbH, Stryker Corporation, and Olympus Corporation.
Cardiopulmonary Stress Testing Systems Market Dynamics and Opportunities Report by Transparency Market Research
The global cardiopulmonary stress testing systems market will exhibit a notable CAGR of 8.20% during the forecast period from 2015 to 2023, says Transparency Market Research (TMR). In 2014, the global cardiopulmonary stress testing systems market was worth US$3.3 bn and by 2023, the market is projected to double in value and be worth US$6.6 bn. The dynamics of the global cardiopulmonary stress testing systems market are shaped by several drivers and restraints. Here are the top 5 trends that will impact the global cardiopulmonary stress testing systems market in the foreseeable future.
5 Key Trends Shaping the Global Cardiopulmonary Stress Testing Systems Market
• Increasing Prevalence of Coronary Artery Disease: Coronary artery disease (CAD) is considered the most common type of heart disease and is a leading cause of death in the U.S. in both women and men. The prevalence of CAD is rising globally, which will drive the global cardiopulmonary stress testing systems market significantly in the coming few years. According to the WHO, around 17.5 mn people died from cardiovascular diseases in 2012, amounting to 31% of global deaths and out of these 7.4 mn were caused by coronary heart disease.
• Rising Obesity Rate: According to the CDC, over one-third of adults in the U.S. are obese. Heart disease is one of the major obesity-related conditions. The growing rate of obesity in the world is projected to drive the global cardiopulmonary stress testing systems market substantially in the coming few years.
• New Technologies: The global cardiopulmonary stress testing systems market will benefit from advancements in technology. The penetration of new monitoring technologies in the market is greatly improving the diagnosis rate.
• Implementation of Legal Provisions: Although the global cardiopulmonary stress testing systems market will expand significantly during the forecast period, it will be suppressed by the implementation of legal provisions such as the Affordable Care Act, promoting cost cutting strategies. The global cardiopulmonary stress testing systems market will also be restrained by the slow growth in the number of SPECT MPI procedures.
• Opportunities in Emerging Nations: Players in the global cardiopulmonary stress testing systems market will benefit from the huge growth potential on offer in emerging markets around the world. China and India are two of the most promising markets for cardiopulmonary stress testing systems. The cardiopulmonary stress testing systems market in the APAC region is projected to progress at the highest CAGR during the forecast period. In addition to this, Brazil and Mexico in the Latin America cardiopulmonary stress testing systems market will witness strong growth in the aforementioned forecast period.
Some of the players operating in multiple avenues in the global cardiopulmonary stress testing systems market are CareFusion Corporation, Philips Healthcare, Spacelabs Healthcare, and GE Healthcare. Other notable players operating in the global cardiopulmonary stress testing systems market are COSMED, Nihon Kohden Corporation, MGC Diagnostic Corporation, SunTech Medical, and Schiller.
Latin America Minimally Invasive Surgery Market to Reach US$1.9 bn Due to Growing Use of Advanced Surgical Devices
The Latin America minimally invasive surgery market is expected to progress at a CAGR of 10.80% between 2014 and 2020. The market was valued at US$925 mn in 2013 and is expected to reach US$1.93 bn by the end of 2020, as mentioned in a research report released by Transparency Market Research, titled “Latin America Minimally Invasive Surgery Market – Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020”.According to the report, the primary growth driver of the Latin America minimally invasive surgery market is the large-scale use of advanced surgical instruments in the recent years. This market provides the benefit of performing low-cost surgeries, adding to its rate of preference.
Browse the full Latin America Minimally Invasive Surgery Market (Surgical Devices, Monitoring & Visualization Devices and Endoscopy Devices) – Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020 report at http://www.transparencymarketresearch.com/latin-america-minimally-invasive-surgery-market.html
The increase in preference of minimally invasive surgeries in Latin America is also attributed to the higher rate of patient comfort in terms of surgical discomfort and reduction in duration of their hospital stay.The report segments the Latin America minimally invasive surgery market according to the categories of product types, type of surgery, and country. From the point of view of product types, the Latin America minimally invasive surgery market was dominated by surgical devices in 2013. This is attributed directly to the growing use of advanced surgical tools that reduce the need for invasive surgery. The fastest growth rate in the product segment is attributed to medical robots.
In terms of types of surgeries, the Latin America minimally invasive surgery market was led by cardiac surgery in 2013 according to revenue. However, the report states that this segment is expected to decline in market share owing to the rapid rate of increase of cosmetic surgeries in Brazil and Mexico. The segments of orthopedic and cosmetic surgeries are expected to witness the fastest rate of growth within the report’s forecast period.
Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3842
Regionally, the Latin America minimally invasive surgery market was led by Brazil and Mexico as the two nations collectively held over 50% of the market in 2013. Mexico is expected to show the fastest growth rate within the report’s forecast period, followed closely by Brazil.The report cites figures by the International Society of Aesthetic Plastic Surgery, which states that there was a 120% increase in the number of cosmetic surgeries in Brazil between 2009 and 2012. This favors the Latin America minimally invasive surgery market to a large extent.
Key players in the Latin America minimally invasive surgery market are Stryker Corporation, Abbott Laboratories, Inc., Varian Medical Systems, Inc., Siemens Healthcare, GE Healthcare, Medtronic, Inc., Teleflex, Covidien plc, DePuy Synthes, Inc., Biomet, Inc., and Philips Healthcare. The top companies of the Latin America minimally invasive surgery market all possess highly advanced product portfolios which allow them to take up larger share in the market.
Key segments of the Latin America Minimally Invasive Surgery Market
Latin America Minimally Invasive Surgery Market, by Product Types
- Surgical Devices
- Ablation Devices
- Radiofrequency Ablation
- Microwave Ablation
- Electrosurgical Devices
- Medical Robotic Systems
- Ablation Devices
- Monitoring & Visualization Devices
- X-Ray Devices
- Computed Tomography (CT) Scanners
- Magnetic Resonance Imaging (MRI) Equipment
- Endoscopy Devices
Latin America Minimally Invasive Surgery Market, by Type of Surgery
- Orthopedic Surgery
- Spinal Surgery
- Joint Replacement Surgery
- Cosmetic Surgery
- Breast Surgery
- Vascular Surgery
- Thoracic Surgery
- Gynecological Surgery
- Bariatric Surgery
- Cardiac Surgery
- Gastrointestinal Surgery
- Urological Surgery
Latin America Minimally Invasive Surgery Market, by Country
Mr. Sudip S
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453
A new market research study by Transparency Market Research, titled “Artificial Organ Bank Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023”, provides a comprehensive analysis of the global artificial organ bank market. The research report comprises market overview, information about the products offered, market trends, challenges, historical data, and forecast statistics. The rising number of renal failure cases owing to unhealthy lifestyles, rising need for dialysis, rapidly increasing incidence of various disorders and the growing aging population, rise in the number of accidents, and tremendous increase in the number of patients who are waiting for organ transplantation are some of the major factors that are expected to boost the demand for artificial organ banks in the global market.
Browse Full Report: http://www.transparencymarketresearch.com/artificial-organ-bank-market.html
Scientists around the world are carrying out research and various studies on biofuel cells, which can help in utilizing the oxygen and glucose in the human body in order to generate electricity. In addition, various technological developments in artificial organ storage and transplant are leading to huge opportunities for artificial organs in the forecast period. On the other hand, high regulatory requirements for artificial organs, their inadequate battery life, and their high prices are expected to hamper the growth of the global artificial organ bank market. Moreover, a patient who has an artificial organ cannot go through any other medical examination or test owing to the magnetic reaction that can take place between the artificial organ implanted and the metal in the testing device.
According to type, the research report has segmented the global artificial organ bank market into organs such as blood vessels, the heart, the kidneys, the liver, the pancreas, eyes, and ears. Among all the types, the kidneys and the heart are the most developed and extensively used artificial organs across the globe. The report has further segmented the global artificial organ bank market on the basis of technology used into mechanical and electrical. Furthermore, the global market for artificial organ bank has been segmented on the basis of bionics into ear bionic, bionic limbs, vision bionic, cardiac bionic, and brain bionic.
The research report has further segmented the global artificial organ bank market on the basis of geography into Latin America, North America, Asia Pacific, Europe, and Rest of the World. Among all these regions, North America leads the global market and is expected to remain in that position throughout the forecast period, followed by Europe.
The report on the global artificial organ bank market further talks about the vendor analysis, which includes company overview, product portfolio, business strategies, financial overview, recent developments, and SWOT analysis. Some of the prominent players operating in the global artificial organ bank market are Berlin Heart GmbH., ABIOMED, Inc., Biomet Inc., HeartWare, Inc., Asahi Kasei Medical Co., Ltd., and Thoratec Corporation.